Acura Pharmaceuticals, Inc.
Original post:
Acurox NDA: FDA schedules Advisory Committee meeting (News-Medical-Net)
Tags: discuss-the-new, has-publically, pharmaceuticals, scheduling
Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) and King Pharmaceuticals, Inc
Tags: pharmaceuticals, relative, relative-abuse, study, today-announced
PALATINE, IL and BRISTOL, TN–(Marketwire – March 8, 2010) – Acura Pharmaceuticals, Inc. ( NASDAQ : ACUR ) and King Pharmaceuticals, Inc. ( NYSE : KG ) today announced top-line results from Study AP-ADF-114 (“Study 114″) titled “A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Relative Abuse Potential of Acurox ® (oxycodone HCl and niacin) Tablets in Non-Dependent …
Go here to read the rest:
Acura Pharmaceuticals and King Pharmaceuticals Announce Positive Top Line Results of a Clinical Study Assessing … (Marketwire)
Tags: pharmaceuticals, relative-abuse, study, today-announced
Cumberland Pharmaceuticals Inc. (CPIX) today announced new top-line results for a patient preference study evaluating Kristalose (lactulose) for Oral Solution, a prescription laxative packaged as a crystalline powder, compared to similar products in liquid forms.
Read the original post:
New top-line results for patient preference study evaluating Kristalose for Oral Solution announced (News-Medical-Net)
Tags: kristalose, liquid-forms-, new-top-line, pharmaceuticals, today-announced
Pharmaceutical executives are laying out plans to prevent the misuse of prescription painkillers, under pressure from regulators trying to prevent hundreds of fatal overdoses each year.
Go here to see the original:
Drugmakers, FDA move to curb painkiller abuse (San Francisco Chronicle)
Tags: drugmakers-want, fatal-overdoses, management, pharmaceutical, pharmaceuticals